Biogen said signals sugget the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose ...
Biogen (NASDAQ:BIIB) shares jumped 10% on Thursday after the company released encouraging Phase 2 data for diranersen, its ...
The 'Veep' alum sat for an hour-long career retrospective conversation on Thursday in Cannes with ‘Awards Chatter' host Scott ...
INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on inflammation and immunology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
From the subtle differences between memory lapses and brain disease to the lifestyle changes that can lower your risk, Dr Tim Beanland at Alzheimer’s Society helps you navigate the facts about dementi ...
The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
CELIA did not meet its primary endpoint assessing dose response; based on the strength of the biomarker and efficacy data, ...
Scientists tracking more than 40,000 people for over 15 years found an intriguing connection between egg consumption and ...
A newly published study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits ...
Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...
Biogen Inc. said it will advance its experimental Alzheimer’s drug after getting promising though inconclusive signs of ...
In a study published in Neurochemistry International, researchers found that arginine reduced the buildup of toxic amyloid β ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results